Announcements

Showing items 11 - 20 of 4859 stories.

Lockman receives continued funding for Tumor Microenvironment research

Paul Lockman, Ph.D., BSN, assistant vice president of Experimental Therapeutics in the West Virginia University School of Medicine Department of Pharmacology and Benedum Fellow and the Mylan Endowed Chair professor in the School of Pharmacy, has received notification of continued funding for the research project “Tumor Microenvironment-TME CoBRE.”

WVU Medicine physician enrolls their first patient in global periprosthetic joint infection clinical trial

WVU Medicine physicians are participating in their second Peptilogics study to treat peri-prosthetic joint infections (PJI) of the knee, which is infection after joint replacement surgery. In 2022, WVU was the first site to dose a patient with a new antimicrobial medication in the Phase 1b clinical trial for the treatment of PJI.  WVU, led by Principal Investigator Dr. Matthew Dietz, is now collaborating on the follow up study, a global Phase 2/3 RETAIN trial, onto which the team has already enrolled its first patient.